Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02500901
Title Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors Paul Mathew, MD
Indications

prostate adenocarcinoma

Therapies

Niraparib

Enzalutamide

Age Groups: adult
Covered Countries USA


No variant requirements are available.